Drug Type Small molecule drug |
Synonyms- |
Action antagonists, inhibitors |
Mechanism EGFR antagonists(Epidermal growth factor receptor erbB1 antagonists), TOP1 inhibitors(DNA topoisomerase I inhibitors), Top II inhibitors(Topoisomerase II inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Colonic Cancer | Preclinical | Egypt | 01 Sep 2025 | |
| Leukemia | Preclinical | Egypt | 01 Sep 2025 | |
| Lymphoma | Preclinical | Egypt | 01 Sep 2025 |





